Breast cancer survivors may have increased risk of thyroid cancer
the ONA take:
According to preliminary findings presented at the annual meeting of the Endocrine Society in San Diego, California, researchers at Columbia University Medical Center in New York City have found that female breast cancer survivors may be at an increased risk for developing thyroid cancer.
For the study, researchers analyzed government data from over 700,000 American women treated for breast cancer.
They found that women had a higher-than-average risk for developing thyroid cancer, mostly within 5 years of the breast cancer diagnosis.
The researchers estimated that a 40-year-old female breast cancer survivor's risk of developing thyroid cancer in the next 10 years was 16% and 12% for a 50-year-old woman, compared with 0.3% for the average U.S. woman.
The findings do not make it clear what causes the association, but it may be related to the thyroid gland being exposed to radiation treatment for breast cancer. In general, the incidence of thyroid cancer is increasing in the United States, possibly due to better detection with the increasing use of thyroid ultrasound.
Female breast cancer survivors may be at an increased risk for developing thyroid cancer.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Self-Predictions for Well-Being Influence Satisfaction After Mastectomy, Breast Reconstruction
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Gabapentin Improves Postoperative Opioid Cessation, But Not Pain Resolution
- Early Integration of Palliative Care Improves Quality of Life in Advanced Cancer
- Cisplatin-Induced Adverse Events in Osteosarcoma Not Improved With Pantoprazole
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Cachexia Not Improved With Celecoxib Plus Megestrol vs Megestrol Alone
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Efficacy and Safety of COX-2 Inhibitors for Advanced Non-small-cell Lung Cancer With Chemotherapy: A Meta-analysis
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|